Cambridge Cognition Holdings Plc (LON:COG – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Thursday . The stock traded as low as GBX 43 ($0.54) and last traded at GBX 46 ($0.58), with a volume of 140710 shares traded. The stock had previously closed at GBX 45.50 ($0.57).
Cambridge Cognition Stock Down 2.2 %
The company’s 50-day moving average price is GBX 52.82 and its 200 day moving average price is GBX 53.20. The company has a debt-to-equity ratio of 18.95, a quick ratio of 0.96 and a current ratio of 0.45. The stock has a market cap of £15.64 million, a PE ratio of -460.00 and a beta of 0.80.
Cambridge Cognition Company Profile
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Read More
- Five stocks we like better than Cambridge Cognition
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- The Real Reason Michael Burry is Buying Physical Gold
- How to Use the MarketBeat Stock Screener
- Investing in 5G Stocks: Still an Opportunity
- Most active stocks: Dollar volume vs share volume
- Cisco Systems Rebound is On: Double-Digit Upside to Come
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.
